These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 6327947)

  • 21. Tc-99m-(V)-DMSA: the new sensitive and specific radiopharmaceutical for imaging metastases of medullary thyroid carcinomas?
    Becker W; Börner W; Reiners C
    Horm Metab Res Suppl; 1989; 21():38-42. PubMed ID: 2553574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The flare phenomenon on radionuclide bone scan in metastatic prostate cancer.
    Pollen JJ; Witztum KF; Ashburn WL
    AJR Am J Roentgenol; 1984 Apr; 142(4):773-6. PubMed ID: 6230903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radionuclide imaging in medullary thyroid carcinoma: evaluation of two new radiopharmaceuticals.
    Clarke SE; Lazarus CR; Maisey MN
    Henry Ford Hosp Med J; 1987; 35(2-3):124-6. PubMed ID: 2826368
    [No Abstract]   [Full Text] [Related]  

  • 24. More on [99mTc](V)DMSA scintigraphy in patients with medullary carcinoma of the thyroid.
    Mojiminiyi OA; Udelsman R; Shepstone BJ; Dudley NE; Soper ND
    J Nucl Med; 1989 Aug; 30(8):1420. PubMed ID: 2547036
    [No Abstract]   [Full Text] [Related]  

  • 25. Tc-99m DMSA scintigraphy on patients with medullary thyroid carcinoma.
    Groth P; Unterspann S; Schwähn D; Stoll I; Reincke R
    Radiobiol Radiother (Berl); 1987; 28(5):642-4. PubMed ID: 2831560
    [No Abstract]   [Full Text] [Related]  

  • 26. Imaging with pentavalent [99mTc]DMSA in patients with medullary cancer of the thyroid.
    Hilditch TE; Murray T; Connell JM; McLellan AR; Reed NS
    J Nucl Med; 1988 Oct; 29(10):1746-7. PubMed ID: 2845025
    [No Abstract]   [Full Text] [Related]  

  • 27. Metastatic prostatic pulmonary nodules with normal bone image.
    Petras AF; Wollett FC
    J Nucl Med; 1983 Nov; 24(11):1026-7. PubMed ID: 6226768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential renal function using technetium-99m dimercaptosuccinic acid (DMSA): in vitro correlation.
    Daly MJ; Jones W; Rudd TG; Tremann J
    J Nucl Med; 1979 Jan; 20(1):63-6. PubMed ID: 219166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Technetium-99m pentavalent DMSA imaging detects metastases of poorly differentiated carcinoma of the thyroid.
    Costa DC; Glynne-Jones R; Falzon M; Lui D; Ryder JP; Ell PJ
    Clin Nucl Med; 1989 Mar; 14(3):218-21. PubMed ID: 2544341
    [No Abstract]   [Full Text] [Related]  

  • 30. Technetium-99m (V) DMSA uptake in amyloidosis.
    Ohta H; Endo K; Kanoh T; Konishi J; Kotoura H
    J Nucl Med; 1989 Dec; 30(12):2049-52. PubMed ID: 2555464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of residual renal function and prediction of the prognosis of polycystic kidney disease by 99m Tc-dimercaptosuccinic acid (DMSA) renal scintigraphy.
    Kawamura J; Yoshida O
    Nihon Jinzo Gakkai Shi; 1981 Jul; 23(7):1031-4. PubMed ID: 6275152
    [No Abstract]   [Full Text] [Related]  

  • 32. Images of liposarcoma using technetium-99m bleomycin and technetium (V)-99m DMSA.
    Ohta H; Shane FI; Endo K; Torizuka K; Horiuchi K; Yokoyama A; Ishii M
    Clin Nucl Med; 1986 Dec; 11(12):842-4. PubMed ID: 2434276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Scintigraphy with technetium dimercaptosuccinic acid (99 m TC DMSA). Contribution to the functional assessment of individual kidneys (author's transl)].
    Abbou CC; Moretti JL; Chopin D; Sanabria E; Msallag M; Nebout T; Auvert J
    Nouv Presse Med; 1981 Apr; 10(18):1475-8. PubMed ID: 6265862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone metastases demonstrated by pentavalent Tc-99m DMSA and Tc-99m HMDP.
    Hirano T; Otake H
    Clin Nucl Med; 1997 Sep; 22(9):640-1. PubMed ID: 9298304
    [No Abstract]   [Full Text] [Related]  

  • 35. Tc-99m DMSA uptake by metastatic colorectal carcinoma.
    Rondogianni P; Koniaris G
    Clin Nucl Med; 2004 Aug; 29(8):485-7. PubMed ID: 15249824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypertension in children. Increased efficacy of technetium Tc 99m succimer in screening for renal disease.
    Rosen PR; Treves S; Ingelfinger J
    Am J Dis Child; 1985 Feb; 139(2):173-7. PubMed ID: 2983528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myocardial infarct imaging in patients with technetium-99m 2,3-dimercaptosuccinic acid. Superiority of technetium-99m pyrophosphate.
    Lyons KP; Milne N; Karlsberg RP; Olson HG; Kuperus J
    Clin Nucl Med; 1987 Jul; 12(7):514-8. PubMed ID: 3038447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bone metastases detected by radionuclide angiography].
    Suzuki K; Miyamae T; Mashita M; Nishimura K
    Rinsho Hoshasen; 1986 Jul; 31(7):841-2. PubMed ID: 3020280
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of technetium-99m pentavalent DMSA in the management of patients with medullary carcinoma of the thyroid.
    Clarke SE; Lazarus C; Mistry R; Maisey MN
    Br J Radiol; 1987 Nov; 60(719):1089-92. PubMed ID: 2825895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pyelonephritis-induced parenchymal defects in children diagnosed by Tc 99m DMSA renal scintigraphy and intravenous urography].
    Biskjaer N; Thelle T
    Ugeskr Laeger; 1983 May; 145(21):1604-7. PubMed ID: 6308868
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.